BioSig Technologies Inc (NASDAQ:BSGM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “BioSig Technologies, Inc. is a medical device company which is engaged in developing technology platform to improve cardiac recording during electrophysiology studies and ablation procedures. BioSig Technologies, Inc. is headquartered in Minnesota. “

BioSig Technologies (NASDAQ:BSGM) remained flat at $1.40 during midday trading on Tuesday. The company had a trading volume of 10,062 shares. The stock’s market cap is $28.67 million. BioSig Technologies has a one year low of $0.90 and a one year high of $2.20. The firm’s 50 day moving average price is $1.39 and its 200 day moving average price is $1.52.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

About BioSig Technologies

BioSig Technologies, Inc is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.

5 Day Chart for NASDAQ:BSGM

Receive News & Ratings for BioSig Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies Inc and related companies with's FREE daily email newsletter.